Marker Therapeutics, Inc.

MRKRNasdaq· Pharmaceutical Preparations

Price History

Revenue

$3.5M

▼ 46.2% YoY

Net Income

-$12.2M

▼ 13.3% YoY

EPS

$-0.79

▲ 33.6% YoY

Cash

$16.1M

▼ 16.3% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.